1 / 5

AI in Pathology Market

Global AI in Pathology Market is estimated to be worth USD 0.015 Billion in 2022 and is projected to grow at a CAGR of 14.2% between 2023 to 2032. The study has considered the base year as 2022, which estimates the market size of market and the forecast period is 2023 to 2032. The report analyzes and forecasts the market size, in terms of value (USD Billion), for the market. The report segments the market and forecasts it by component, by neural network, by application, by end user and region/country.<br><br>

Dhanashri3
Download Presentation

AI in Pathology Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global AI in Pathology Market Skyrockets to USD 0.015 Billion in 2022, Anticipates Staggering 14.2% CAGR Momentum Through 2032 The Global AI in Pathology Market has witnessed unprecedented growth, estimated to be worth USD 0.015 Billion in 2022, and is projected to maintain its momentum with a compelling CAGR of 14.2% from 2023 to 2032. This transformative market, situated at the crossroads of healthcare and technology, is harnessing the power of artificial intelligence (AI) to redefine pathology practices. The study, considering 2022 as the base year, meticulously analyzes and forecasts the market size in terms of value (USD Billion). It further segments the market by component, neural network, application, end user, and region/country, offering a comprehensive outlook on the evolving landscape of AI in pathology. The growth of the global AI in pathology market is underpinned by AI’s remarkable potential to elevate diagnostic accuracy, enhance efficiency, and optimize workflow in pathology practices. AI-powered solutions are proving instrumental in assisting

  2. pathologists to analyze and interpret complex medical imaging data, such as digitized slides and tissue samples, leading to quicker and more accurate diagnoses. Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.sanglobalresearch.com/request-sample/3146 These advanced systems play a pivotal role in identifying anomalies, predicting disease progression, and offering personalized treatment recommendations, ushering in a new era of disease detection and patient care. The increasing adoption of digital pathology and machine learning algorithms for image analysis, coupled with collaborations between healthcare institutions and AI technology providers, is propelling the expansion of this market. Regional Insights: North America: At the forefront of AI integration in pathology, North America, particularly the United States and Canada, boasts advanced healthcare infrastructure and significant investments in AI and machine learning technologies. Leading healthcare institutions actively explore AI-powered solutions to improve diagnostic accuracy and enhance patient care. Europe: European countries, including the United Kingdom, Germany, and France, are progressively embracing AI in pathology. Initiatives focused on leveraging AI algorithms for pathology image analysis and enhancing diagnostic capabilities are driving adoption across the continent. Asia-Pacific: Countries such as Japan, China, South Korea, and Australia in the Asia-Pacific region are exploring AI applications in pathology, facilitated by growing healthcare infrastructure and initiatives promoting technological advancements in healthcare. Other Regions: Adoption in Latin America, the Middle East, and Africa is at early stages, with ongoing initiatives and pilot projects influencing the gradual integration of AI in pathology. Market Drivers: The global AI in pathology market is propelled by several key factors, including the growing need for improved diagnostic accuracy and efficiency. AI technologies offer the potential to enhance diagnoses by assisting pathologists in analyzing vast amounts of medical imaging data with greater speed and accuracy. The increasing volume of pathology samples and a shortage of pathologists have created a demand for AI solutions that can aid in image analysis, pattern recognition, and anomaly detection.

  3. Opportunities: The evolving market presents opportunities to augment pathologists’ capabilities through AI-driven tools, streamlining workflows, reducing diagnostic errors, and enhancing treatment decisions. AI-driven pathology solutions also facilitate personalized medicine by tailoring treatment plans based on patient data and pathology images, contributing to improved patient outcomes. Get Customization on AI in Pathology Market: https://www.sanglobalresearch.com/customization/3146 Key Companies Profiled: Indica Labs, Akoya Biosciences, Inc., Hologic, Inc., Aiforia Technologies, OptraSCAN, Tribun Health, Mindpeak GmbH, Techcyte., Lumea, aetherAI 雲象科技 雲象科技 Global AI in Pathology Market Segmentation: The Global AI in Pathology Market is segmented by component, by neural network, by application, by end user and region/country. By Component: Based on the Component, the Global AI in Pathology Market is bifurcated into Software & Scanners — where the Software is dominating and ahead in terms of share. In the Global AI in Pathology Market, software applications play a pivotal role in leveraging artificial intelligence (AI) to revolutionize pathology practices. Image analysis software stands as a cornerstone, employing machine learning algorithms to interpret and analyze digital pathology images, aiding pathologists in identifying anomalies, patterns, and potential diagnoses. Workflow management software streamlines the pathology process, automating tasks, managing sample tracking, and optimizing operational efficiency. Diagnostic decision support software assists pathologists by providing insights and recommendations derived from AI algorithms, aiding in accurate diagnoses and treatment decisions.   By Neural Network: Based on the Neural Network the Global AI in Pathology Market is bifurcated into GAN, CNN & RNN — where GAN is dominating and ahead in terms of share. 

  4. By Application: Based on the Application, the Global AI in Pathology Market is bifurcated into Drug Discovery, Disease Diagnosis & Prognosis, Clinical Overflow and Training & Education — where the Drug Discovery is dominating and ahead of others in terms of share.  By End User: Based on the End User, the Global AI in Pathology Market is bifurcated into Pharma & Bio Tech Companies, Hospitals & Labs and Research Institutes — where the Pharma & Bio Tech Companies is dominating and ahead of others in terms of share.  On the basis of region North America Europe Asia Pacific South America and Middle East and Africa      Our Latest Reports: Digital Twin Market: https://www.sanglobalresearch.com/report/digital-twin- market/3150 Wound Care Market: https://www.sanglobalresearch.com/report/wound-care- market/3154 Hand Held X-Rays Market: https://www.sanglobalresearch.com/report/hand-held-x- rays-market/3155

  5. About Us: At San Global Research Report, we pride ourselves on our commitment to quality and accuracy. Our team of experienced researchers utilizes a combination of quantitative and qualitative methods to ensure that our findings are both accurate and reliable. With a strong emphasis on responsiveness, transparency, and collaboration, we work closely with our clients to understand their objectives and deliver actionable insights. Learn more about our research approach and how it can benefit your business. Contact Us: Phone: +91 9209275355 Email Id: hello@sanglobalresearch.com

More Related